Nanoparticle-based anti-Myc cancer therapeutics

基于纳米颗粒的抗 Myc 癌症疗法

• 批准号: 296093
• 负责人: Shin Jumi
• 金额: $ 32.64万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-10-01 至 2016-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=296093&lang=en
• 关键词: Anti-Cancer Therapeutics; B1h; Chip & Chip-Chip; Enhancer Box (E-Box); Mammalian Cell Lines; Myc-Dependent Transformation; Myc/Max Transcription Factors; Nanotechnology & Nanodelivery; Protein Design & Directed Evolution; Protein:Dna Interactions; Y1h; Y2

We are designing new drugs that can combat cancer. These drugs are based on natural proteins, which are abundant in your body and make your body function. We take these building blocks and design super protein drugs. One of our drugs interferes with a kn

我们正在设计能对抗癌症的新药。这些药物是基于天然蛋白质，这是丰富的在你的身体，使你的身体功能。我们利用这些基础材料来设计超级蛋白质药物。 我们的一种药物会干扰